Low Testosterone and Depression: What's the Link?

Depression in men is underdiagnosed, undertreated, and frequently has a direct hormonal component that conventional psychiatric care does not assess. The relationship between testosterone and mood is well-established in the endocrinological literature, but rarely makes it into the primary care consultation room where most depressed men first present.

Understanding the testosterone-mood connection is not about medicalising sadness. It is about recognising that for a substantial proportion of depressed men, the primary driver of their depression is hormonal rather than psychological, and that treating the hormonal deficit produces far better outcomes than antidepressants alone.

The Biological Connection Between Testosterone and Mood

Testosterone influences mood through multiple direct mechanisms in the brain:

• Serotonin system: Testosterone upregulates the expression of serotonin receptors (particularly 5-HT2A) and increases serotonin synthesis capacity in limbic regions. Low testosterone reduces the serotonergic tone that conventional antidepressants attempt to enhance artificially.
• Dopamine system: Testosterone promotes dopamine synthesis and receptor sensitivity in the mesolimbic reward circuit. Low testosterone is directly associated with anhedonia (inability to experience pleasure), the most treatment-resistant symptom of depression.
• BDNF expression: Testosterone promotes BDNF synthesis in hippocampal tissue. BDNF deficiency is increasingly recognised as central to depression biology. This provides a mechanism for testosterone's antidepressant effects independent of its mood-specific receptor actions.
• HPA axis regulation: Testosterone reduces cortisol reactivity and HPA axis hyperactivation. Low testosterone allows unchecked stress responses that chronically elevate cortisol, which itself causes depression.
• Neuroinflammation: Testosterone has anti-inflammatory effects in brain tissue. Low testosterone is associated with elevated neuroinflammatory markers that independently cause depressive symptoms.

The Epidemiological Evidence

The population-level data is consistent:

• Men with hypogonadism (clinically low testosterone) have two to three times the rate of depression compared to eugonadal men
• The severity of depression symptoms correlates inversely with testosterone levels in cross-sectional studies
• Testosterone replacement therapy (TRT) in hypogonadal depressed men produces significant improvement in depression scores in multiple randomised controlled trials
• Men with "low-normal" testosterone who are treated see mood improvements, suggesting the optimal range for mood is the upper half of the reference range, not merely being "above the low threshold"

The Bidirectional Relationship

The testosterone-depression relationship is bidirectional, which is why it can become a self-reinforcing cycle:

• Low testosterone causes depression through the biological mechanisms above
• Depression causes low testosterone through chronic cortisol elevation (which suppresses GnRH and LH) and through the lifestyle consequences of depression (reduced exercise, poor sleep, poor nutrition), all of which further suppress testosterone

Breaking this cycle requires addressing both sides: treating the testosterone deficiency to address its direct mood effects, and addressing the depression and lifestyle factors that are suppressing testosterone.

Men Who Should Get Testosterone Tested for Depression

Any man presenting with depression should have testosterone tested if he has:

• Depression onset or worsening after age 35
• Depression accompanied by low libido, reduced motivation, fatigue, or reduced morning erections
• Depression that has not responded adequately to antidepressant therapy
• Depression in the context of weight gain, particularly central fat gain
• Depression in the context of reduced exercise performance or physical capacity

The testosterone blood test is simple, inexpensive, and routinely available, yet it is ordered in a small minority of depressed men in standard care.

Treatment Approaches

Restoring Endogenous Testosterone (Peptide-Based)

For men without primary testicular failure, kisspeptin and enclomiphene restore the hypothalamic and pituitary signalling that drives natural testosterone production. This approach preserves fertility and avoids the testicular suppression associated with exogenous testosterone administration.

Kisspeptin directly activates GnRH neurons to restore LH pulsatility and downstream testosterone production. Enclomiphene blocks oestrogen's negative feedback at the pituitary, increasing LH and FSH drive. Both are effective in men whose testosterone is suppressed by stress, lifestyle, or functional hypogonadism.

Direct Testosterone Replacement (TRT)

For men with primary hypogonadism where the testicular function itself is impaired, direct testosterone replacement may be required. Longegra's physicians assess which approach is clinically appropriate based on LH, FSH, and testosterone levels.

Addressing Concurrent Drivers

Optimising sleep (GH peptides, sleep hygiene), reducing cortisol burden (Selank, stress management), and normalising body composition (body recomposition peptides and nutrition) are essential complementary interventions. Testosterone optimisation in a patient who remains significantly sleep-deprived, obese, and chronically stressed will be less effective than in a patient where these factors are addressed together.